+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
U.S. Lateral Flow Assay Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Lateral Flow Readers), By Application (Veterinary Diagnostics, Food Safety & Environment Testing), By Technique, By End use, And Segment Forecasts, 2025 - 2033- Product Image
U.S. Lateral Flow Assay Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Lateral Flow Readers), By Application (Veterinary Diagnostics, Food Safety & Environment Testing), By Technique, By End use, And Segment Forecasts, 2025 - 2033- Product Image
New

U.S. Lateral Flow Assay Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Lateral Flow Readers), By Application (Veterinary Diagnostics, Food Safety & Environment Testing), By Technique, By End use, And Segment Forecasts, 2025 - 2033

  • PDF Icon

    Report

  • 100 Pages
  • June 2025
  • Region: United States
  • Grand View Research
  • ID: 6111313
Description Jump to:

U.S. Lateral Flow Assay Market Trends

The U.S. lateral flow assay market size was valued at USD 2.82 billion in 2024 and is projected to reach USD 4.63 billion by 2033, growing at a CAGR of 6.08% from 2025 to 2033. The rising prevalence of infectious diseases places immense pressure on public health systems worldwide. With increasing urbanization, interconnectivity, antimicrobial resistance, and the rising impact of climate change, experts stress the urgent need for enhanced infectious disease surveillance, prevention, and diagnostic capabilities. The global rise in infectious diseases significantly drives the lateral flow assays (LFA) market by necessitating rapid diagnostic solutions. According to the Centers for Disease Control and Prevention (CDC), tuberculosis (TB) cases in the U.S. increased from 7,874 in 2022 to 10,347 in 2024, reflecting a notable public health challenge.

The mosquito-borne disease testing segment is projected to experience significant growth due to the rising prevalence of mosquito-borne infections, including West Nile virus (WNV), dengue, chikungunya, Zika virus, malaria, and yellow fever. The increasing incidence of these diseases has heightened the demand for rapid and efficient diagnostic solutions, particularly in regions prone to outbreaks. According to the Centers for Disease Control and Prevention (CDC), West Nile virus (WNV) has become endemic in the U.S., with cases reported in all 48 contiguous states and the District of Columbia, predominantly during the summer and fall months. As of November 2024, the CDC recorded 1,466 cases of WNV, while in 2022, 913 human cases were reported, with 70% classified as neuroinvasive and 30% as non-neuroinvasive. The increasing burden of mosquito-borne diseases, alongside ongoing health crises such as COVID-19 and monkeypox, underscores the urgent need for effective diagnostic and surveillance measures.

Public health initiatives also play a crucial role in market expansion. The CDC’s Influenza Division International Program focuses on surveillance, pandemic preparedness, research, and vaccination programs to combat influenza. Additionally, the National Association of County and City Health Officials supports local health departments in influenza prevention and control.

U.S. Lateral Flow Assay Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. lateral flow assay market report based on product, application, technique, and end use:

Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Kits & Reagents
  • Lateral Flow Readers
  • Benchtop Readers
  • Digital Readers

Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Clinical Testing
  • Infectious Disease Testing
  • COVID-19
  • Mosquito Borne Disease Testing
  • Malaria Testing
  • Dengue Testing
  • Zika Testing
  • Chikungunya Testing
  • Others
  • Influenza Testing
  • Sexually Transmitted Infection Testing
  • HIV Testing
  • HPV Testing
  • Chlamydia Testing
  • Gonorrhea Testing
  • Syphilis Testing
  • Other STI Testing
  • Hepatitis
  • Tuberculosis
  • Other Infectious Diseases
  • Cardiac Marker Testing
  • Troponin I and T Testing
  • CK-MB Testing
  • BNP and NT-Probnp Testing
  • Myoglobin Testing
  • D-Dimer Testing
  • Other Cardiac Marker Tests
  • Pregnancy & Fertility Testing
  • Pregnancy Testing
  • Fertility Testing
  • Cholesterol Testing/Lipid Profile
  • Drugs of Abuse Testing
  • Other Clinical Tests
  • Veterinary Diagnostics
  • Food Safety & Environment Testing
  • Drug Development & Quality Testing

Technique Outlook (Revenue, USD Million, 2021 - 2033)

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays

End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care
  • Pharmaceutical & Biotechnology Companies
  • Others

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Lateral Flow Assay Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.1.1. Increasing prevalence of infectious diseases
3.3.1.2. Technological advancements in lateral flow
3.3.1.3. Growing adoption in homecare settings
3.3.2. Market Restraints Analysis
3.3.2.1. Stringent Regulations
3.3.3. Market Opportunities Analysis
3.3.3.1. Growing demand for Point-of-Care (POC) Testing
3.3.3.2. Expanding applications beyond healthcare
3.3.4. Market Challenges Analysis
3.3.4.1. Product Recalls
3.4. U.S. Lateral Flow Assay Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. U.S. Lateral Flow Assay Market: Product Estimates & Trend Analysis
4.1. U.S. Lateral Flow Assay Market: Product Movement Analysis
4.2. U.S. Lateral Flow Assay Market Estimates and Forecasts, by Product 2024 & 2033 (USD Million)
4.3. Kits & Reagents
4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Lateral Flow Readers
4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2. Benchtop Readers
4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. Digital Readers
4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Lateral Flow Assay Market: Application Estimates & Trend Analysis
5.1. U.S. Lateral Flow Assay Market: Application Movement Analysis
5.2. U.S. Lateral Flow Assay Market Estimates and Forecasts, by Application 2024 & 2033 (USD Million)
5.3. Clinical Testing
5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2. Infectious Disease Testing
5.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.2. COVID-19
5.3.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.3. Mosquito Borne Disease Testing
5.3.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.3.2. Malaria Testing
5.3.2.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.3.3. Dengue Testing
5.3.2.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.3.4. Zika Testing
5.3.2.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.3.5. Chikungunya Testing
5.3.2.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.3.6. Others
5.3.2.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.4. Influenza Testing
5.3.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.5. Sexually Transmitted Infection Testing
5.3.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.5.2. HIV Testing
5.3.2.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.5.3. HPV Testing
5.3.2.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.5.4. Chlamydia Testing
5.3.2.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.5.5. Gonorrhea Testing
5.3.2.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.5.6. Syphilis Testing
5.3.2.5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.5.7. Other STI Testing
5.3.2.5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.6. Hepatitis
5.3.2.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.7. Tuberculosis
5.3.2.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.2.8. Other Infectious Diseases
5.3.2.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.3. Cardiac Marker Testing
5.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.3.2. Troponin I and T Testing
5.3.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.3.3. CK-MB Testing
5.3.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.3.4. BNP and NT-Probnp Testing
5.3.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.3.5. Myoglobin Testing
5.3.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.3.6. D-Dimer Testing
5.3.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.3.7. Other Cardiac Marker Tests
5.3.3.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.4. Pregnancy & Fertility Testing
5.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.4.2. Pregnancy Testing
5.3.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.4.3. Fertility Testing
5.3.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.5. Cholesterol Testing/Lipid Profile
5.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.6. Drugs of Abuse Testing
5.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3.7. Other Clinical Tests
5.3.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Veterinary Diagnostics
5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Food Safety & Environment Testing
5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Drug Development & Quality Testing
5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Lateral Flow Assay Market: Technique Estimates & Trend Analysis
6.1. U.S. Lateral Flow Assay Market: Technique Movement Analysis
6.2. U.S. Lateral Flow Assay Market Estimates and Forecasts, by Technique 2024 & 2033 (USD Million)
6.3. Sandwich Assays
6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Competitive Assays
6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Multiplex Detection Assays
6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Lateral Flow Assay Market: End Use Estimates & Trend Analysis
7.1. U.S. Lateral Flow Assay Market: End-use Movement Analysis
7.2. U.S. Lateral Flow Assay Market Estimates and Forecasts, by End-use 2024 & 2033 (USD Million)
7.3. Hospitals & Clinics
7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. Diagnostic Laboratories
7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Home Care
7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Pharmaceutical & Biotechnology Companies
7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Other End-use
7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Abbott
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Bio-Rad Laboratories, Inc
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Siemens Healthineers AG
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. BIOMÉRIEUX
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. BD
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. QIAGEN
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. QuidelOrtho Corporation
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. F. Hoffmann-La Roche
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. DH Life Sciences, LLC.
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Quest Diagnostics
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of abbreviations
Table 2 U.S. lateral flow assay market, by region, 2018 - 2033 (USD Million)
Table 3 U.S. lateral flow assay market, by product, 2018 - 2033 (USD Million)
Table 4 U.S. lateral flow assay market, by technique, 2018 - 2033 (USD Million)
Table 5 U.S. lateral flow assay market, by application, 2018 - 2033 (USD Million)
Table 6 U.S. lateral flow assay market, by end-use, 2018 - 2033 (USD Million)
List of Figures
Fig. 1 U.S. lateral flow assay market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 U.S. lateral flow assay market: Product outlook key takeaways
Fig. 20 U.S. lateral flow assay market: Product movement analysis
Fig. 21 Kits & reagents market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Lateral flow readers market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 Benchtop readers market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Digital readers market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 U.S. lateral flow assay market: Application outlook key takeaways
Fig. 26 U.S. lateral flow assay market: Application movement analysis
Fig. 27 Clinical testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Infectious disease testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 COVID-19 market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Mosquito borne disease testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Malaria Testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 Dengue Testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 33 Zika Testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Chikungunya Testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Influenza testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 Sexually transmitted infection testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 HIV testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 HPV testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 40 Chlamydia testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 Gonorrhea testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 Syphilis testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Other STI testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 Hepatitis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 45 Tuberculosis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 46 Other infectious diseases market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 Cardiac marker testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 Troponin I and t testing
Fig. 49 CK-MB testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 50 BNP and NT-PROBNP testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 51 Myoglobin testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 52 D-dimer testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 53 Other cardiac marker tests market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 54 Pregnancy & fertility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 55 Pregnancy testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 56 Fertility testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 57 Cholesterol testing/lipid profile market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 58 Drugs of abuse testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 59 Other clinical tests market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 60 Veterinary diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 61 Food safety & environment testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 62 Drug development & quality testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 63 U.S. lateral flow assay market: Technique outlook key takeaways
Fig. 64 U.S. lateral flow assay market: Technique movement analysis
Fig. 65 Sandwich assays market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 66 Competitive assays market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 67 Multiplex detection assays market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 68 U.S. Lateral Flow Assay market: Test Type outlook key takeaways
Fig. 69 U.S. Lateral Flow Assay market: Test Type movement analysis
Fig. 70 Lateral flow immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 71 Nucleic acid lateral flow assay market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 72 U.S. Lateral Flow Assay market: End-use outlook key takeaways
Fig. 73 U.S. Lateral Flow Assay market: End-use movement analysis
Fig. 74 Hospitals & clinics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 75 Diagnostic laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 76 Home care market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 77 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 78 Other End-use market estimates and forecasts, 2021 - 2033 (USD Million)

Companies Mentioned

  • Abbott
  • Bio-Rad Laboratories, Inc
  • Siemens Healthineers AG
  • BIOMÉRIEUX
  • BD
  • QIAGEN
  • QuidelOrtho Corporation
  • F. Hoffmann-La Roche
  • DH Life Sciences, LLC.
  • Quest Diagnostics

Table Information

Report AttributeDetails
No. of Pages100
PublishedJune 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 2.82 Billion
Forecasted Market Value ( USD ) by 2033 $ 4.63 Billion
Compound Annual Growth Rate6.0%
Regions CoveredUnited States
No. of Companies Mentioned10

Related Topics

Related Reports

U.S. Minimal Residual Disease Testing Market Size, Share & Trends Analysis Report By Technology (Flow Cytometry, PCR, NGS), By Cancer Type (Hematological Malignancy, Solid Tumors), By End Use, And Segment Forecasts, 2025 - 2033 - Product Image

U.S. Minimal Residual Disease Testing Market Size, Share & Trends Analysis Report By Technology (Flow Cytometry, PCR, NGS), By Cancer Type (Hematological Malignancy, Solid Tumors), By End Use, And Segment Forecasts, 2025 - 2033

  • Report
  • 100 Pages
  • United States
From
Lateral Flow Assays Market Size, Share & Trends Analysis Report By Product (Kits, Lateral Flow Readers), By Technique (Sandwich Assays, Competitive Assays), By Application, By Test, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Lateral Flow Assays Market Size, Share & Trends Analysis Report By Product (Kits, Lateral Flow Readers), By Technique (Sandwich Assays, Competitive Assays), By Application, By Test, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 176 Pages
  • Global
From
U.S. And Europe Lateral Flow Assay Market Size, Share & Trends Analysis Report Product (Kits & Reagents, Lateral Flow Readers), By Application, By Technique, By Test Type, By End Use, By Country, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. And Europe Lateral Flow Assay Market Size, Share & Trends Analysis Report Product (Kits & Reagents, Lateral Flow Readers), By Application, By Technique, By Test Type, By End Use, By Country, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Europe, United States Europe, United States
From
Microplates Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033 - Product Image

Microplates Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033

  • Report
  • 173 Pages
  • Global
From
Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Opportunities and Strategies to 2033 - Product Image

Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Opportunities and Strategies to 2033

  • Report
  • 293 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.